Given the common use of ACE inhibitors and ARBs worldwide, guidance on the use of these drugs in patients with Covid-19 is urgently needed. Here, we highlight that the data in humans are too limited ...
In a meta-analysis of 33 randomized controlled trials, Makani and colleagues 1 compared efficacy and safety outcomes in patients treated by blockade of the renin–angiotensin–aldosterone system (RAAS) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results